Neurotensin Modulates the Electrical Activity of Frog Pituitary Melanotropes via Activation of a G-Protein-Coupled Receptor Pharmacologically Related to Both the NTS1 and nts2 Receptors of Mammals
The primary structure of frog neurotensin (fNT) has recently been determined and it has been shown that fNT is a potent stimulator of α-MSH secretion by frog pituitary melanotropes. In the present study, we have investigated the effects of fNT on the electrical activity of cultured frog melanotropes...
Gespeichert in:
Veröffentlicht in: | Neuroendocrinology 2000-12, Vol.72 (6), p.379-391 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 391 |
---|---|
container_issue | 6 |
container_start_page | 379 |
container_title | Neuroendocrinology |
container_volume | 72 |
creator | Belmeguenai, Amor Vaudry, Hubert Leprince, Jérôme Vivet, Bertrand Cavelier, Florine Martinez, Jean Louiset, Estelle |
description | The primary structure of frog neurotensin (fNT) has recently been determined and it has been shown that fNT is a potent stimulator of α-MSH secretion by frog pituitary melanotropes. In the present study, we have investigated the effects of fNT on the electrical activity of cultured frog melanotropes by using the patch-clamp technique and we have determined the pharmacological profile of the receptors mediating the effect of fNT. In the cell-attached configuration, fNT (10 –7 M) provoked an increase in the action current discharge followed by an arrest of spike firing. In the gramicidin-perforated patch configuration, fNT (10 –7 M) induced a depolarization accompanied by an increase in action potential frequency and a decrease in membrane resistance. Administration of graded concentrations (10 –10 to 10 –6 M) of fNT or the C-terminal hexapeptide NT(8–13) caused a dose-dependent increase in the frequency of action potentials with EC 50 of 2 × 10 –8 and 5 × 10 –9 M, respectively. The stimulatory effect of fNT was mimicked by various pseudopeptide analogs, with the following order of potency: Boc-[Trp 11 ]NT(8–13) > Boc-[D-Trp 11 ]NT(8–13) > Boc-[Lys 8,9 , Nal 11 ]NT(8–13) > Boc-[Ψ11,12]NT(8–13). In contrast, the cyclic pseudopeptide analogs of NT(8–13), Lys-Lys-Pro-D-Trp-Ile-Leu and Lys-Lys-Pro-D-Trp-Glu-Leu-OH, did not affect the electrical activity. The NTS1 receptor antagonist and nts2 receptor agonist SR 48692 (10 –5 M) stimulated the spike discharge but did not block the response to fNT. In contrast, SR 142948A (10 –5 M), another NTS1 receptor antagonist and nts2 receptor agonist, inhibited the excitatory effect of fNT. The specific nts2 receptor ligand levocabastine (10 –6 M) had no effect on the basal electrical activity and the response of melanotropes to fNT. In cells which were dialyzed with guanosine-5′-O-(3-thiotriphosphate) (10 –4 M), fNT caused an irreversible stimulation of the action potential discharge. Conversely, dialysis of melanotropes with guanosine-5′-O-(2-thiodiphosphate) (10 –4 M) completely blocked the effect of fNT. Pretreatment of cells with cholera toxin (1 µg/ml) or pertussis toxin (0.2 µg/ml) did not affect the electrical response to fNT. Intracellular application of the G o/i/s protein antagonist GPAnt-1 (3 × 10 –5 M) had no effect on the fNT-evoked stimulation. In contrast, dialysis of melanotropes with the G q/11 protein antagonist GPAnt-2A (3 × 10 –5 M) abrogated the response to fNT. The present data demonstrate t |
doi_str_mv | 10.1159/000054607 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_11146421</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18072635</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-c1f0f75d647c8266cf6f53199c8c8269ab3320ee70478befff4247b304d99e3</originalsourceid><addsrcrecordid>eNqFkk2P0zAQhiMEYsvCgTMS8gmJQ1h_xUmOpdoPpHap2L1HrjNuDU7ctZ1K_X_8MBxSdY_ry8j2M-87Hk-WfST4GyFFfYXTKrjA5atsRjhlOSY1f53NMKZVzipWXGTvQvidKFoz-ja7IIRwwSmZZX_vYfAuQh9Mj1auHayMEFDcAbq2oKI3Slo0V9EcTDwip9GNd1u0NnEwUfojWoGVvYve7VPawciJldG4fqQlus3Xo4Hp84Ub9hZa9AsU7KPzaL2TvpPKWbcdbewxXY3-LYoOfXdx97-O-8cHgmTfoj4Gek4Oo_pKdp204X32RqcAH07xMnu4uX5c3OXLn7c_FvNlrpgQMVdEY10WreClqqgQSgtdMFLXqhr3tdwwRjFAiXlZbUBrzSkvNwzztq6BXWZfJ9WdtM3emy49v3HSNHfzZTOepa4LLIQ4kMR-mdi9d08DhNh0JiiwqVfghtCUtGBUVMWLIKlwSQUrnt2VdyF40OcSCG7GKWjOU5DYzyfRYdNB-0yevj0Bnybgj_Rb8GdgSv8HSX-3Iw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18072635</pqid></control><display><type>article</type><title>Neurotensin Modulates the Electrical Activity of Frog Pituitary Melanotropes via Activation of a G-Protein-Coupled Receptor Pharmacologically Related to Both the NTS1 and nts2 Receptors of Mammals</title><source>MEDLINE</source><source>Karger Journals Complete</source><creator>Belmeguenai, Amor ; Vaudry, Hubert ; Leprince, Jérôme ; Vivet, Bertrand ; Cavelier, Florine ; Martinez, Jean ; Louiset, Estelle</creator><creatorcontrib>Belmeguenai, Amor ; Vaudry, Hubert ; Leprince, Jérôme ; Vivet, Bertrand ; Cavelier, Florine ; Martinez, Jean ; Louiset, Estelle</creatorcontrib><description>The primary structure of frog neurotensin (fNT) has recently been determined and it has been shown that fNT is a potent stimulator of α-MSH secretion by frog pituitary melanotropes. In the present study, we have investigated the effects of fNT on the electrical activity of cultured frog melanotropes by using the patch-clamp technique and we have determined the pharmacological profile of the receptors mediating the effect of fNT. In the cell-attached configuration, fNT (10 –7 M) provoked an increase in the action current discharge followed by an arrest of spike firing. In the gramicidin-perforated patch configuration, fNT (10 –7 M) induced a depolarization accompanied by an increase in action potential frequency and a decrease in membrane resistance. Administration of graded concentrations (10 –10 to 10 –6 M) of fNT or the C-terminal hexapeptide NT(8–13) caused a dose-dependent increase in the frequency of action potentials with EC 50 of 2 × 10 –8 and 5 × 10 –9 M, respectively. The stimulatory effect of fNT was mimicked by various pseudopeptide analogs, with the following order of potency: Boc-[Trp 11 ]NT(8–13) > Boc-[D-Trp 11 ]NT(8–13) > Boc-[Lys 8,9 , Nal 11 ]NT(8–13) > Boc-[Ψ11,12]NT(8–13). In contrast, the cyclic pseudopeptide analogs of NT(8–13), Lys-Lys-Pro-D-Trp-Ile-Leu and Lys-Lys-Pro-D-Trp-Glu-Leu-OH, did not affect the electrical activity. The NTS1 receptor antagonist and nts2 receptor agonist SR 48692 (10 –5 M) stimulated the spike discharge but did not block the response to fNT. In contrast, SR 142948A (10 –5 M), another NTS1 receptor antagonist and nts2 receptor agonist, inhibited the excitatory effect of fNT. The specific nts2 receptor ligand levocabastine (10 –6 M) had no effect on the basal electrical activity and the response of melanotropes to fNT. In cells which were dialyzed with guanosine-5′-O-(3-thiotriphosphate) (10 –4 M), fNT caused an irreversible stimulation of the action potential discharge. Conversely, dialysis of melanotropes with guanosine-5′-O-(2-thiodiphosphate) (10 –4 M) completely blocked the effect of fNT. Pretreatment of cells with cholera toxin (1 µg/ml) or pertussis toxin (0.2 µg/ml) did not affect the electrical response to fNT. Intracellular application of the G o/i/s protein antagonist GPAnt-1 (3 × 10 –5 M) had no effect on the fNT-evoked stimulation. In contrast, dialysis of melanotropes with the G q/11 protein antagonist GPAnt-2A (3 × 10 –5 M) abrogated the response to fNT. The present data demonstrate that fNT is a potent stimulator of the electrical activity of frog pituitary melanotropes. These results also reveal that the electrophysiological response evoked by fNT can be accounted for by activation of a G q/11 -protein-coupled receptor subtype whose pharmacological profile shares similarities with those of mammalian NTS1 and nts2 receptors.</description><identifier>ISSN: 0028-3835</identifier><identifier>EISSN: 1423-0194</identifier><identifier>DOI: 10.1159/000054607</identifier><identifier>PMID: 11146421</identifier><language>eng</language><publisher>Basel, Switzerland: Karger</publisher><subject>Adamantane ; Adamantane - analogs & derivatives ; Adamantane - pharmacology ; Animals ; Anura ; Cell Behavior ; Cells, Cultured ; Cellular Biology ; Chemical Sciences ; GTP-Binding Protein alpha Subunits, Gq-G11 ; Guanosine 5'-O-(3-Thiotriphosphate) ; Guanosine 5'-O-(3-Thiotriphosphate) - pharmacology ; Guanosine Diphosphate ; Guanosine Diphosphate - analogs & derivatives ; Guanosine Diphosphate - pharmacology ; Heterotrimeric GTP-Binding Proteins ; Heterotrimeric GTP-Binding Proteins - metabolism ; Imidazoles ; Imidazoles - pharmacology ; Life Sciences ; Ligands ; Male ; Mammals ; Medicinal Chemistry ; Melanocytes ; Melanocytes - drug effects ; Melanocytes - metabolism ; melanotropes ; Membrane Potentials ; Membrane Potentials - drug effects ; Membrane Potentials - physiology ; Neurobiology ; Neurons and Cognition ; Neurotensin ; Neurotensin - metabolism ; Neurotensin - pharmacology ; neurotensin receptors ; Patch-Clamp Techniques ; Peptide Fragments ; Peptide Fragments - metabolism ; Peptide Fragments - pharmacology ; Pharmaceutical sciences ; Pharmacology ; Pituitary Cell Biology ; Pituitary Gland ; Pituitary Gland - cytology ; Pyrazoles ; Pyrazoles - pharmacology ; Quinolines ; Quinolines - pharmacology ; Rana ; Rana ridibunda ; Receptors, Neurotensin ; Receptors, Neurotensin - metabolism ; Signal Transduction ; Signal Transduction - drug effects ; Signal Transduction - physiology ; Thionucleotides ; Thionucleotides - pharmacology</subject><ispartof>Neuroendocrinology, 2000-12, Vol.72 (6), p.379-391</ispartof><rights>2000 S. Karger AG, Basel</rights><rights>Copyright 2000 S. Karger AG, Basel</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-c1f0f75d647c8266cf6f53199c8c8269ab3320ee70478befff4247b304d99e3</citedby><cites>FETCH-LOGICAL-c366t-c1f0f75d647c8266cf6f53199c8c8269ab3320ee70478befff4247b304d99e3</cites><orcidid>0000-0001-5308-6416 ; 0000-0002-7814-9927 ; 0000-0002-4723-095X ; 0000-0003-3295-3095</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,2429,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11146421$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://normandie-univ.hal.science/hal-01960666$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Belmeguenai, Amor</creatorcontrib><creatorcontrib>Vaudry, Hubert</creatorcontrib><creatorcontrib>Leprince, Jérôme</creatorcontrib><creatorcontrib>Vivet, Bertrand</creatorcontrib><creatorcontrib>Cavelier, Florine</creatorcontrib><creatorcontrib>Martinez, Jean</creatorcontrib><creatorcontrib>Louiset, Estelle</creatorcontrib><title>Neurotensin Modulates the Electrical Activity of Frog Pituitary Melanotropes via Activation of a G-Protein-Coupled Receptor Pharmacologically Related to Both the NTS1 and nts2 Receptors of Mammals</title><title>Neuroendocrinology</title><addtitle>Neuroendocrinology</addtitle><description>The primary structure of frog neurotensin (fNT) has recently been determined and it has been shown that fNT is a potent stimulator of α-MSH secretion by frog pituitary melanotropes. In the present study, we have investigated the effects of fNT on the electrical activity of cultured frog melanotropes by using the patch-clamp technique and we have determined the pharmacological profile of the receptors mediating the effect of fNT. In the cell-attached configuration, fNT (10 –7 M) provoked an increase in the action current discharge followed by an arrest of spike firing. In the gramicidin-perforated patch configuration, fNT (10 –7 M) induced a depolarization accompanied by an increase in action potential frequency and a decrease in membrane resistance. Administration of graded concentrations (10 –10 to 10 –6 M) of fNT or the C-terminal hexapeptide NT(8–13) caused a dose-dependent increase in the frequency of action potentials with EC 50 of 2 × 10 –8 and 5 × 10 –9 M, respectively. The stimulatory effect of fNT was mimicked by various pseudopeptide analogs, with the following order of potency: Boc-[Trp 11 ]NT(8–13) > Boc-[D-Trp 11 ]NT(8–13) > Boc-[Lys 8,9 , Nal 11 ]NT(8–13) > Boc-[Ψ11,12]NT(8–13). In contrast, the cyclic pseudopeptide analogs of NT(8–13), Lys-Lys-Pro-D-Trp-Ile-Leu and Lys-Lys-Pro-D-Trp-Glu-Leu-OH, did not affect the electrical activity. The NTS1 receptor antagonist and nts2 receptor agonist SR 48692 (10 –5 M) stimulated the spike discharge but did not block the response to fNT. In contrast, SR 142948A (10 –5 M), another NTS1 receptor antagonist and nts2 receptor agonist, inhibited the excitatory effect of fNT. The specific nts2 receptor ligand levocabastine (10 –6 M) had no effect on the basal electrical activity and the response of melanotropes to fNT. In cells which were dialyzed with guanosine-5′-O-(3-thiotriphosphate) (10 –4 M), fNT caused an irreversible stimulation of the action potential discharge. Conversely, dialysis of melanotropes with guanosine-5′-O-(2-thiodiphosphate) (10 –4 M) completely blocked the effect of fNT. Pretreatment of cells with cholera toxin (1 µg/ml) or pertussis toxin (0.2 µg/ml) did not affect the electrical response to fNT. Intracellular application of the G o/i/s protein antagonist GPAnt-1 (3 × 10 –5 M) had no effect on the fNT-evoked stimulation. In contrast, dialysis of melanotropes with the G q/11 protein antagonist GPAnt-2A (3 × 10 –5 M) abrogated the response to fNT. The present data demonstrate that fNT is a potent stimulator of the electrical activity of frog pituitary melanotropes. These results also reveal that the electrophysiological response evoked by fNT can be accounted for by activation of a G q/11 -protein-coupled receptor subtype whose pharmacological profile shares similarities with those of mammalian NTS1 and nts2 receptors.</description><subject>Adamantane</subject><subject>Adamantane - analogs & derivatives</subject><subject>Adamantane - pharmacology</subject><subject>Animals</subject><subject>Anura</subject><subject>Cell Behavior</subject><subject>Cells, Cultured</subject><subject>Cellular Biology</subject><subject>Chemical Sciences</subject><subject>GTP-Binding Protein alpha Subunits, Gq-G11</subject><subject>Guanosine 5'-O-(3-Thiotriphosphate)</subject><subject>Guanosine 5'-O-(3-Thiotriphosphate) - pharmacology</subject><subject>Guanosine Diphosphate</subject><subject>Guanosine Diphosphate - analogs & derivatives</subject><subject>Guanosine Diphosphate - pharmacology</subject><subject>Heterotrimeric GTP-Binding Proteins</subject><subject>Heterotrimeric GTP-Binding Proteins - metabolism</subject><subject>Imidazoles</subject><subject>Imidazoles - pharmacology</subject><subject>Life Sciences</subject><subject>Ligands</subject><subject>Male</subject><subject>Mammals</subject><subject>Medicinal Chemistry</subject><subject>Melanocytes</subject><subject>Melanocytes - drug effects</subject><subject>Melanocytes - metabolism</subject><subject>melanotropes</subject><subject>Membrane Potentials</subject><subject>Membrane Potentials - drug effects</subject><subject>Membrane Potentials - physiology</subject><subject>Neurobiology</subject><subject>Neurons and Cognition</subject><subject>Neurotensin</subject><subject>Neurotensin - metabolism</subject><subject>Neurotensin - pharmacology</subject><subject>neurotensin receptors</subject><subject>Patch-Clamp Techniques</subject><subject>Peptide Fragments</subject><subject>Peptide Fragments - metabolism</subject><subject>Peptide Fragments - pharmacology</subject><subject>Pharmaceutical sciences</subject><subject>Pharmacology</subject><subject>Pituitary Cell Biology</subject><subject>Pituitary Gland</subject><subject>Pituitary Gland - cytology</subject><subject>Pyrazoles</subject><subject>Pyrazoles - pharmacology</subject><subject>Quinolines</subject><subject>Quinolines - pharmacology</subject><subject>Rana</subject><subject>Rana ridibunda</subject><subject>Receptors, Neurotensin</subject><subject>Receptors, Neurotensin - metabolism</subject><subject>Signal Transduction</subject><subject>Signal Transduction - drug effects</subject><subject>Signal Transduction - physiology</subject><subject>Thionucleotides</subject><subject>Thionucleotides - pharmacology</subject><issn>0028-3835</issn><issn>1423-0194</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk2P0zAQhiMEYsvCgTMS8gmJQ1h_xUmOpdoPpHap2L1HrjNuDU7ctZ1K_X_8MBxSdY_ry8j2M-87Hk-WfST4GyFFfYXTKrjA5atsRjhlOSY1f53NMKZVzipWXGTvQvidKFoz-ja7IIRwwSmZZX_vYfAuQh9Mj1auHayMEFDcAbq2oKI3Slo0V9EcTDwip9GNd1u0NnEwUfojWoGVvYve7VPawciJldG4fqQlus3Xo4Hp84Ub9hZa9AsU7KPzaL2TvpPKWbcdbewxXY3-LYoOfXdx97-O-8cHgmTfoj4Gek4Oo_pKdp204X32RqcAH07xMnu4uX5c3OXLn7c_FvNlrpgQMVdEY10WreClqqgQSgtdMFLXqhr3tdwwRjFAiXlZbUBrzSkvNwzztq6BXWZfJ9WdtM3emy49v3HSNHfzZTOepa4LLIQ4kMR-mdi9d08DhNh0JiiwqVfghtCUtGBUVMWLIKlwSQUrnt2VdyF40OcSCG7GKWjOU5DYzyfRYdNB-0yevj0Bnybgj_Rb8GdgSv8HSX-3Iw</recordid><startdate>20001201</startdate><enddate>20001201</enddate><creator>Belmeguenai, Amor</creator><creator>Vaudry, Hubert</creator><creator>Leprince, Jérôme</creator><creator>Vivet, Bertrand</creator><creator>Cavelier, Florine</creator><creator>Martinez, Jean</creator><creator>Louiset, Estelle</creator><general>Karger</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>F1W</scope><scope>H95</scope><scope>L.G</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-5308-6416</orcidid><orcidid>https://orcid.org/0000-0002-7814-9927</orcidid><orcidid>https://orcid.org/0000-0002-4723-095X</orcidid><orcidid>https://orcid.org/0000-0003-3295-3095</orcidid></search><sort><creationdate>20001201</creationdate><title>Neurotensin Modulates the Electrical Activity of Frog Pituitary Melanotropes via Activation of a G-Protein-Coupled Receptor Pharmacologically Related to Both the NTS1 and nts2 Receptors of Mammals</title><author>Belmeguenai, Amor ; Vaudry, Hubert ; Leprince, Jérôme ; Vivet, Bertrand ; Cavelier, Florine ; Martinez, Jean ; Louiset, Estelle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-c1f0f75d647c8266cf6f53199c8c8269ab3320ee70478befff4247b304d99e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adamantane</topic><topic>Adamantane - analogs & derivatives</topic><topic>Adamantane - pharmacology</topic><topic>Animals</topic><topic>Anura</topic><topic>Cell Behavior</topic><topic>Cells, Cultured</topic><topic>Cellular Biology</topic><topic>Chemical Sciences</topic><topic>GTP-Binding Protein alpha Subunits, Gq-G11</topic><topic>Guanosine 5'-O-(3-Thiotriphosphate)</topic><topic>Guanosine 5'-O-(3-Thiotriphosphate) - pharmacology</topic><topic>Guanosine Diphosphate</topic><topic>Guanosine Diphosphate - analogs & derivatives</topic><topic>Guanosine Diphosphate - pharmacology</topic><topic>Heterotrimeric GTP-Binding Proteins</topic><topic>Heterotrimeric GTP-Binding Proteins - metabolism</topic><topic>Imidazoles</topic><topic>Imidazoles - pharmacology</topic><topic>Life Sciences</topic><topic>Ligands</topic><topic>Male</topic><topic>Mammals</topic><topic>Medicinal Chemistry</topic><topic>Melanocytes</topic><topic>Melanocytes - drug effects</topic><topic>Melanocytes - metabolism</topic><topic>melanotropes</topic><topic>Membrane Potentials</topic><topic>Membrane Potentials - drug effects</topic><topic>Membrane Potentials - physiology</topic><topic>Neurobiology</topic><topic>Neurons and Cognition</topic><topic>Neurotensin</topic><topic>Neurotensin - metabolism</topic><topic>Neurotensin - pharmacology</topic><topic>neurotensin receptors</topic><topic>Patch-Clamp Techniques</topic><topic>Peptide Fragments</topic><topic>Peptide Fragments - metabolism</topic><topic>Peptide Fragments - pharmacology</topic><topic>Pharmaceutical sciences</topic><topic>Pharmacology</topic><topic>Pituitary Cell Biology</topic><topic>Pituitary Gland</topic><topic>Pituitary Gland - cytology</topic><topic>Pyrazoles</topic><topic>Pyrazoles - pharmacology</topic><topic>Quinolines</topic><topic>Quinolines - pharmacology</topic><topic>Rana</topic><topic>Rana ridibunda</topic><topic>Receptors, Neurotensin</topic><topic>Receptors, Neurotensin - metabolism</topic><topic>Signal Transduction</topic><topic>Signal Transduction - drug effects</topic><topic>Signal Transduction - physiology</topic><topic>Thionucleotides</topic><topic>Thionucleotides - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Belmeguenai, Amor</creatorcontrib><creatorcontrib>Vaudry, Hubert</creatorcontrib><creatorcontrib>Leprince, Jérôme</creatorcontrib><creatorcontrib>Vivet, Bertrand</creatorcontrib><creatorcontrib>Cavelier, Florine</creatorcontrib><creatorcontrib>Martinez, Jean</creatorcontrib><creatorcontrib>Louiset, Estelle</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Neuroendocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Belmeguenai, Amor</au><au>Vaudry, Hubert</au><au>Leprince, Jérôme</au><au>Vivet, Bertrand</au><au>Cavelier, Florine</au><au>Martinez, Jean</au><au>Louiset, Estelle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neurotensin Modulates the Electrical Activity of Frog Pituitary Melanotropes via Activation of a G-Protein-Coupled Receptor Pharmacologically Related to Both the NTS1 and nts2 Receptors of Mammals</atitle><jtitle>Neuroendocrinology</jtitle><addtitle>Neuroendocrinology</addtitle><date>2000-12-01</date><risdate>2000</risdate><volume>72</volume><issue>6</issue><spage>379</spage><epage>391</epage><pages>379-391</pages><issn>0028-3835</issn><eissn>1423-0194</eissn><abstract>The primary structure of frog neurotensin (fNT) has recently been determined and it has been shown that fNT is a potent stimulator of α-MSH secretion by frog pituitary melanotropes. In the present study, we have investigated the effects of fNT on the electrical activity of cultured frog melanotropes by using the patch-clamp technique and we have determined the pharmacological profile of the receptors mediating the effect of fNT. In the cell-attached configuration, fNT (10 –7 M) provoked an increase in the action current discharge followed by an arrest of spike firing. In the gramicidin-perforated patch configuration, fNT (10 –7 M) induced a depolarization accompanied by an increase in action potential frequency and a decrease in membrane resistance. Administration of graded concentrations (10 –10 to 10 –6 M) of fNT or the C-terminal hexapeptide NT(8–13) caused a dose-dependent increase in the frequency of action potentials with EC 50 of 2 × 10 –8 and 5 × 10 –9 M, respectively. The stimulatory effect of fNT was mimicked by various pseudopeptide analogs, with the following order of potency: Boc-[Trp 11 ]NT(8–13) > Boc-[D-Trp 11 ]NT(8–13) > Boc-[Lys 8,9 , Nal 11 ]NT(8–13) > Boc-[Ψ11,12]NT(8–13). In contrast, the cyclic pseudopeptide analogs of NT(8–13), Lys-Lys-Pro-D-Trp-Ile-Leu and Lys-Lys-Pro-D-Trp-Glu-Leu-OH, did not affect the electrical activity. The NTS1 receptor antagonist and nts2 receptor agonist SR 48692 (10 –5 M) stimulated the spike discharge but did not block the response to fNT. In contrast, SR 142948A (10 –5 M), another NTS1 receptor antagonist and nts2 receptor agonist, inhibited the excitatory effect of fNT. The specific nts2 receptor ligand levocabastine (10 –6 M) had no effect on the basal electrical activity and the response of melanotropes to fNT. In cells which were dialyzed with guanosine-5′-O-(3-thiotriphosphate) (10 –4 M), fNT caused an irreversible stimulation of the action potential discharge. Conversely, dialysis of melanotropes with guanosine-5′-O-(2-thiodiphosphate) (10 –4 M) completely blocked the effect of fNT. Pretreatment of cells with cholera toxin (1 µg/ml) or pertussis toxin (0.2 µg/ml) did not affect the electrical response to fNT. Intracellular application of the G o/i/s protein antagonist GPAnt-1 (3 × 10 –5 M) had no effect on the fNT-evoked stimulation. In contrast, dialysis of melanotropes with the G q/11 protein antagonist GPAnt-2A (3 × 10 –5 M) abrogated the response to fNT. The present data demonstrate that fNT is a potent stimulator of the electrical activity of frog pituitary melanotropes. These results also reveal that the electrophysiological response evoked by fNT can be accounted for by activation of a G q/11 -protein-coupled receptor subtype whose pharmacological profile shares similarities with those of mammalian NTS1 and nts2 receptors.</abstract><cop>Basel, Switzerland</cop><pub>Karger</pub><pmid>11146421</pmid><doi>10.1159/000054607</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0001-5308-6416</orcidid><orcidid>https://orcid.org/0000-0002-7814-9927</orcidid><orcidid>https://orcid.org/0000-0002-4723-095X</orcidid><orcidid>https://orcid.org/0000-0003-3295-3095</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-3835 |
ispartof | Neuroendocrinology, 2000-12, Vol.72 (6), p.379-391 |
issn | 0028-3835 1423-0194 |
language | eng |
recordid | cdi_pubmed_primary_11146421 |
source | MEDLINE; Karger Journals Complete |
subjects | Adamantane Adamantane - analogs & derivatives Adamantane - pharmacology Animals Anura Cell Behavior Cells, Cultured Cellular Biology Chemical Sciences GTP-Binding Protein alpha Subunits, Gq-G11 Guanosine 5'-O-(3-Thiotriphosphate) Guanosine 5'-O-(3-Thiotriphosphate) - pharmacology Guanosine Diphosphate Guanosine Diphosphate - analogs & derivatives Guanosine Diphosphate - pharmacology Heterotrimeric GTP-Binding Proteins Heterotrimeric GTP-Binding Proteins - metabolism Imidazoles Imidazoles - pharmacology Life Sciences Ligands Male Mammals Medicinal Chemistry Melanocytes Melanocytes - drug effects Melanocytes - metabolism melanotropes Membrane Potentials Membrane Potentials - drug effects Membrane Potentials - physiology Neurobiology Neurons and Cognition Neurotensin Neurotensin - metabolism Neurotensin - pharmacology neurotensin receptors Patch-Clamp Techniques Peptide Fragments Peptide Fragments - metabolism Peptide Fragments - pharmacology Pharmaceutical sciences Pharmacology Pituitary Cell Biology Pituitary Gland Pituitary Gland - cytology Pyrazoles Pyrazoles - pharmacology Quinolines Quinolines - pharmacology Rana Rana ridibunda Receptors, Neurotensin Receptors, Neurotensin - metabolism Signal Transduction Signal Transduction - drug effects Signal Transduction - physiology Thionucleotides Thionucleotides - pharmacology |
title | Neurotensin Modulates the Electrical Activity of Frog Pituitary Melanotropes via Activation of a G-Protein-Coupled Receptor Pharmacologically Related to Both the NTS1 and nts2 Receptors of Mammals |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T05%3A32%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neurotensin%20Modulates%20the%20Electrical%20Activity%20of%20Frog%20Pituitary%20Melanotropes%20via%20Activation%20of%20a%20G-Protein-Coupled%20Receptor%20Pharmacologically%20Related%20to%20Both%20the%20NTS1%20and%20nts2%20Receptors%20of%20Mammals&rft.jtitle=Neuroendocrinology&rft.au=Belmeguenai,%20Amor&rft.date=2000-12-01&rft.volume=72&rft.issue=6&rft.spage=379&rft.epage=391&rft.pages=379-391&rft.issn=0028-3835&rft.eissn=1423-0194&rft_id=info:doi/10.1159/000054607&rft_dat=%3Cproquest_pubme%3E18072635%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18072635&rft_id=info:pmid/11146421&rfr_iscdi=true |